Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE (DD-MM-YYYY)2. REPORT TYPE 3. DATES COVERED (From -To) 4. TITLE AND SUBTITLE 5a. CONTRACT NUMBER 5b. GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) 5d. PROJECT NUMBER 5e. TASK NUMBER E-Mail:5f. WORK UNIT NUMBER The main objective of the proposal is to understand how the Mre11-Rad50-Nbs1 complex and the BRCA1-BARD1 complex interact on DNA and coordinate DNA transactions that are critical for the maintenance of genomic stability and to prevent breast tumor development. We have characterized the behavior of BRCA1/BARD1 on DNA, using a single molecule approach. We have developed new single molecule technologies to study the behavior of BRCA1/BARD1 and MRN complexes. Finally, we have established that MRN-BRAC1/BARD1 interactions are dispensable for MRN/CtIP dependent DNA end resection, the first step of homology-dependent repair of DNA double-strand breaks.
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)
U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTNo subject terms provided. We have completed initial characterization of quantum dot(QD)-tagged Brac1/Bard1 interactions with dsDNA using our single molecule DNA curtain imaging technology. We have shown that the QD tagged protein complexes work in our single molecule assays, that the labeling is specific, and that the labeled proteins are well-behaved in our single molecule assays. We have also demonstrated that BRCA1/BARD1 binds double stranded DNA at apparently random locations, and that the protein appears to undergo one-dimensional (1D) diffusion along the DNA in a direction that is biased by buffer flow (see below) before finally stopping at a fixed location (unpublished). We do not yet know the significance of the 1D sliding behavior nor do we know what DNA features influence the binding distributions, but it seems reasonable to expect that these properties reflect mechanistic attributes of BRCA1/BARD1 as it searc...